Who is sponsoring NCT04691336?

NCT04691336 is sponsored by Air Liquide Healthcare Spain.

What drugs are being tested in NCT04691336?

Interventions in NCT04691336: Educational and Training with counselling.

What condition does NCT04691336 study?

NCT04691336 studies COPD, ILD, Dyspnea.

Is NCT04691336 still recruiting?

NCT04691336 is currently completed. Last updated 31 December 2020.

Last reviewed 2020-12-31 · How we verify

NCT04691336: PIMAOX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Individualized Plan for Improving Adherence to Portable Oxygen Therapy in Patients With Respiratory Pathology

Completed NA Last updated 31 December 2020

What this trial tests

NA trial testing Educational and Training with counselling in COPD in 22 participants. Completed in 30 September 2019.

Timeline

1 March 2019

Primary endpoint
26 April 2019

30 September 2019

Quick facts

Lead sponsor	Air Liquide Healthcare Spain
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	1 March 2019
Primary completion	26 April 2019
Estimated completion	30 September 2019
Sites	1 location across Spain

Drugs / interventions tested

Educational and Training with counselling

Conditions studied

COPD — all drugs for COPD →
ILD — all drugs for ILD →
Dyspnea — all drugs for Dyspnea →

Sponsor

Air Liquide Healthcare Spain — full company profile →

Who can join

18 and older, any sex, with COPD or ILD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pilot study with patients with prescription of portable oxygen therapy, to test the impact on adherence of a patient-centered empowerment program, with contents on the nature of the respiratory pathology, the symptom of dyspnea, the benefits of the therapy, adjustment expectations and beliefs, as well as health habits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for COPD

Currently open trials in the same condition.

NCT07344649 — Turkish Validation of the Nijmegen Questionnaire in COPD · recruiting
NCT07524023 — Emotional-distress-based Integrated Care Programme in Patients With Stable COPD · NA · recruiting
NCT07460154 — Structured Review: To Optimise Management and Prevent Harm in COPD · NA · recruiting
NCT07462221 — Effect of Telenursing on Oral Health · NA · recruiting
NCT07051707 — Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD · NA · recruiting

Other Air Liquide Healthcare Spain trials

Trials by the same sponsor.

NCT04650061 — PIMA - Individualized Adherence Improvement Plan · NA · unknown
NCT07258264 — MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuo · NA · completed
NCT04691479 — Adherence and Quality of Life of CPAP for Obstructive Sleep Apnea · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04691336 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Air Liquide Healthcare Spain
Last refreshed: 31 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04691336.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing